(+1) 88 700 600
310 West 14th North Street, NY

About Viotika

Viotika Life Sciences Inc. was incorporated in 2018 to accelerate the promising research and explore the commercial potential of its platform as a solution for the global AMR crisis. The company was launched in Winnipeg, Canada, and has offices in Winnipeg and in Littleton, Massachusetts.

The work initially focused exclusively on NQR, a novel protein target, and was advanced through the University of Manitoba and the St. Boniface Hospital Research Centre.

Today, Viotika’s expanded science team is building on the original research and expanding the scope beyond NQR. This expanded scope, shaped by new discoveries, comes at a critical time as conventional antibiotics are becoming increasingly ineffective against infections.

Our Vision

A world where no one dies because of antimicrobial resistance.

Our Mission

To advance our breakthrough, generational science; to develop new tools to fight bacterial infections; and to prepare these tools for market, with the support of visionary investors and partners.